Skip to main content

Table 1 General characteristics

From: Prognostic implications of tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio in septic shock patients

Categories

Survivors (n = 75)

Non-survivors (n = 43)

p value

Age (yr)

59.3 ± 15.3

67.6 ± 14.1

0.004

Sex (male, %)

47 (62.6%)

29 (67.4%)

0.590

APACHE II

18 (14, 22)

26 (19, 30)

< 0.001

SOFA

12 (10, 13)

14 (12, 16)

< 0.001

Diagnosis (n, %)

 Pneumonia

15 (20.0%)

13 (30.2%)

0.208

 Abdominal infection

38 (50.7%)

17 (39.5%)

0.250

 Biliary tract infection

4 (5.3%)

2 (4.7%)

0.863

 CRBSI

4 (5.3%)

2 (4.7%)

0.863

 Cellulitis

10 (13.3%)

5 (11.6%)

0.802

 Others*

4 (5.3%)

4 (9.3%)

0.405

Comorbidities

 HTN

36 (48.0%)

25 (58.1%)

0.284

 DM

28 (37.3%)

22 (51.2%)

0.143

 CAD

14 (18.7%)

13 (30.2%)

0.147

 CKD

5 (6.7%)

6 (14.0%)

0.194

 COPD

7 (9.3%)

8 (18.6%)

0.151

 Timing of echo (hr from admission)

12 (8,18)

13 (9, 16)

0.905

 Maximum NE dose (μg/kg/min)

0.36 (0.18, 0.75)

0.81 (0.40, 1.61)

0.001

 Fluid administered (ml)

2560 (1366, 3140)

2880 (1629, 3530)

0.766

 Lactate (mmol/L)

3.5 (2.7, 4.2)

4.0 (3.3, 4.9)

0.185

 MV duration (hr)

108 (67, 240)

203 (105, 340)

0.051

 ICU length of stay (day)

7 (4, 12)

10 (6, 15)

0.233

  1. TAPSE tricuspid annular plane systolic excursion, APACHE acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, UTI urinary tract infection, CRBSI catheter related bloodstream infection, HTN hypertension, DM diabetes mellitus, CAD coronary arterial disease, CKD chronic kidney dysfunction, COPD chronic obstructive pulmonary disease, NE norepinephrine, ICU intensive care unit
  2. *Others including urinary tract infection, intracranial, mediastinum infections